KP Tissue Inc's stock has taken a hit, closing down 0.38% in the latest trading session, raising concerns among investors.
In the latest trading session, KP Tissue Inc (KPT.TO) saw its stock price decline by 0.38%, closing at CA$13.23. This downturn comes despite the company’s recent announcement of a quarterly dividend and positive financial metrics, leaving investors questioning the underlying reasons for the stock's weakness.
Advertisement
Get up to $2,000 cash back
Open and fund a new Qtrade account with promo code SPRING26. Offer ends July 31, 2026.
KP Tissue Inc
KPT.TO
KPT.TO
KP Tissue Inc
WealthAwesomeMarket cap
$131.06M
P/E
14.5x
52W high
$13.61
52W low
$8.20
1W change
-0.53%
Beta
0.40
Analyst Price Targets
Based on analyst covering KPT
Wall Street analysts forecast KPT stock price to fall 5.3% over the next 12 months.
Consensus
Moderately BearishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$12.38
-5.3% Upside
Current Price
C$13.07
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on KPT's historical volatility
30-Day Vol
20.3%
Annualized
90-Day Vol
16.4%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$15.63
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$13.87 | C$12.94 – C$14.88 |
| 60 trading days | C$14.72 | C$13.34 – C$16.25 |
| 90 trading days | C$15.63 | C$13.84 – C$17.64 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: While KP Tissue's fundamentals appear stable, the recent stock price drop may signal investor uncertainty or market reactions to broader economic conditions.
KP Tissue Inc's stock down 0.38% in one trading day.
With a market cap of CA$131.76 million and a P/E ratio of 14.76, KP Tissue's valuation metrics suggest it remains relatively affordable, but investor sentiment is crucial for recovery.
Bull case
KP Tissue's recent earnings report showed a solid increase in adjusted EBITDA, indicating that the company is operating well and may have the potential for a stock price recovery.
Bear case
The slight revenue decline and lack of significant news might have led to investor hesitation, contributing to the stock's downward movement.
Current Performance Overview
KP Tissue Inc's stock closed down 0.38% at CA$13.23 in the last trading session. This decline comes amidst a backdrop of stable financial performance, including a recent quarterly dividend declaration of CA$0.21 per share. However, the market's reaction suggests that investors are cautious, possibly due to the slight revenue decline reported in the company's latest earnings.
Factors Influencing Investor Sentiment
Despite showing a 14.6% year-over-year increase in adjusted EBITDA, KP Tissue's revenue dip of 0.3% may have raised red flags for investors. Additionally, the absence of significant news to catalyze a positive outlook could be contributing to the stock's recent weakness. As KP Tissue prepares for its upcoming annual meeting, shareholders will be looking for reassurances about the company's direction and growth prospects.
Advertisement
